how many people take glp-1 drugs The Evolution of Users Products - Data Briefs -
Description
Among the GLP-1 medications included in this study, the authors found semaglutide showed a stronger association with reduced AFib risk than liraglutide, dulaglutide and tirzepatide.
Cardiovascular effects of DPP-4 inhibition: Beyond GLP-1
In the STEP UP clinical trial, the 7.2-mg dose demonstrated a mean weight loss of 20.7% at 72 weeks, compared with a reduction of 17.5% with the previously approved semaglutide (Wegovy) injection (2.4 mg) and 2.4% with placebo
The potential link between Mounjaro and eye twitching may be caused by electrolyte imbalances resulting from gastrointestinal side effects like nausea, vomiting, and diarrhea
Therefore, the choice between Mounjaro vs Ozempic in type 2 diabetes should depend on medical advice as well as individual treatment goals
